HIGH-VOLUME · FEMALE-LED
teriparatide Side Effects
teriparatide (also sold as Forteo) is HIGH-VOLUME in this FAERS book #68 of 524 by FAERS report count. Signature opener: FEMALE-LED - 91% of sex-coded reports are female (99,360 F / 10,239 M).
Data updated 2026-05-15
- 111,257
- FAERS reports
FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
teriparatide reporting skew - 91% of sex-coded reports are female (99,360 F / 10,239 M). Volume band HIGH-VOLUME #68 of 524 by FAERS report count; caseload MEGA-CASE.
High-report extract for teriparatide (Forteo): 111,257 FAERS rows (2004-2025). Top named reactions: NAUSEA, ARTHRALGIA, PAIN IN EXTREMITY. Outcome stamps DEATH-MARKED · HOSP-MID · FEMALE-LED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2004–2025). Stamps MEGA-CASE · DEATH-MARKED · HOSP-MID · FEMALE-LED.
NAUSEA leads 8,956 of 111,257 reports
FEMALE-LED reporters · age peak 75+
Female-led reporters (91% of sex-coded rows)
Age peak 75+ (25,089 reports)
Reporting taper since 2004 peak
Reactions in Death Reports
Death appears on 5,261 reports (4.7% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 2,901 |
| PNEUMONIA | 401 |
| FALL | 263 |
| MYOCARDIAL INFARCTION | 192 |
| DYSPNOEA | 162 |
| CEREBROVASCULAR ACCIDENT | 161 |
| RENAL FAILURE | 160 |
| RESPIRATORY FAILURE | 155 |
| CARDIAC ARREST | 149 |
| ASTHENIA | 139 |
| CARDIAC FAILURE | 139 |
| HOSPITALISATION | 135 |
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 134 |
| MALAISE | 126 |
| CARDIAC FAILURE CONGESTIVE | 114 |
| CARDIAC DISORDER | 111 |
| SEPSIS | 111 |
| PAIN | 107 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 102 |
| NAUSEA | 91 |
Reactions in Hospitalization Reports
Hospitalization mid-share (23,997, 21.6%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| FALL | 3,935 |
| PNEUMONIA | 1,575 |
| HOSPITALISATION | 1,503 |
| ASTHENIA | 1,397 |
| PAIN | 1,383 |
| MALAISE | 1,349 |
| BACK PAIN | 1,318 |
| NAUSEA | 1,299 |
| DIZZINESS | 1,192 |
| PAIN IN EXTREMITY | 1,127 |
| PHARMACEUTICAL PRODUCT COMPLAINT | 1,120 |
| DYSPNOEA | 1,106 |
| FATIGUE | 1,049 |
| ARTHRALGIA | 1,029 |
| HIP FRACTURE | 934 |
| VOMITING | 854 |
| GAIT DISTURBANCE | 726 |
| DIARRHOEA | 702 |
| HEADACHE | 694 |
| WEIGHT DECREASED | 677 |
How to read teriparatide FAERS figures (MEGA-CASE · DEATH-MARKED · HOSP-MID)
FAERS holds 111,257 voluntary reports linked to teriparatide (Forteo), 2004-2025. Death is listed on 5,261 (4.7%). Hospitalization appears on 23,997 (21.6%). Top co-reported indication: Osteoporosis.
MEGA-CASE books overweight common drugs and loud reporting cultures; FEMALE-LED is the page opener, not a per-patient risk.
Read with teriparatide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 112,198 FAERS cases (Δ 941 heavier vs teriparatide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 110,018 FAERS cases (Δ 1,239 lighter vs teriparatide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 109,698 FAERS cases (Δ 1,559 lighter vs teriparatide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(total_reports) peer at 109,144 FAERS cases (Δ 2,113 lighter vs teriparatide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-MARKED · HOSP-MID · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 57.4 pp vs teriparatide's DEATH-MARKED): CASELOAD · HOSP-MID.
teriparatide sits in MEGA-CASE; high report volume tracks exposure and reporting culture more than per-patient risk. Methodology states the de-dup rules.